| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |